Wendy Gilmore
Overview
Explore the profile of Wendy Gilmore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kashani N, Kelland E, Vajdi B, Anderson L, Gilmore W, Lund B
Front Immunol
. 2021 Nov;
12:706278.
PMID: 34777337
Alemtuzumab is a highly effective treatment for relapsing-remitting multiple sclerosis. It selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with...
2.
Gilmore W, Lund B, Li P, Levy A, Kelland E, Akbari O, et al.
J Neuroinflammation
. 2020 Jun;
17(1):189.
PMID: 32539719
Objective: To characterize long-term repopulation of peripheral immune cells following alemtuzumab-induced lymphopenia in relapsing-remitting MS (RRMS), with a focus on regulatory cell types, and to explore associations with clinical outcome...
3.
4.
5.
Bove R, Gilmore W
Mult Scler
. 2018 Jan;
24(1):17-21.
PMID: 29307303
Sex differences in epidemiological, clinical, and pathological features of multiple sclerosis (MS) have been observed for decades, establishing a foundation for more recent progress in our understanding of their overall...
6.
7.
Kelland E, Gilmore W, Hayardeny L, Weiner L, Lund B
J Neurol Sci
. 2014 Aug;
346(1-2):66-74.
PMID: 25125045
Laquinimod is an orally active immunomodulatory small molecule that has shown clear clinical benefit in trials for relapsing-remitting multiple sclerosis and in experimental rodent models that emulate multiple sclerosis (MS)....
8.
Lund B, Kelland E, Hayardeny L, Barilan O, Gilmore W, Weiner L
J Neuroimmunol
. 2013 Aug;
263(1-2):108-15.
PMID: 23920036
Laquinimod is a novel orally active agent with immunomodulatory properties that was shown to be effective in suppressing disease activity in relapsing-remitting multiple sclerosis patients. Though many mechanisms of action...
9.
Kelland E, Gilmore W, Weiner L, Lund B
Glia
. 2012 Mar;
59(12):1864-78.
PMID: 22407782
Research into multiple sclerosis (MS) has shown that cells purportedly important to myelin repair within the CNS, namely neural stem cells (NSC) and oligodendrocyte progenitor cells (OPC), are recruited to...
10.
Taylor L, Puranam K, Gilmore W, Ting J, Matsushima G
Neurobiol Dis
. 2010 Mar;
39(2):127-37.
PMID: 20347981
In addition to regulating reproductive functions in the brain and periphery, estrogen has tropic and neuroprotective functions in the central nervous system (CNS). Estrogen administration has been demonstrated to provide...